Saphnelo™ Approved as Self-Administered Autoinjector
The U.S. Food and Drug Administration just granted approval for a self-administered, once-weekly autoinjector of Saphenlo (anifrolumab), for the treatment of adult patients...
Saphnelo
Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting
November 9, 2021
Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College...
Important Message from CEO Kenneth Farber: U.S. FDA Approves New Lupus Treatment
August 2, 2021
Dear Friend of the Lupus Research Alliance,
As we reported this morning, the lupus community has much to...
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons
NEW YORK, NY....